Rein Therapeutics
RNTX
#10029
Rank
NZ$49.71 M
Marketcap
NZ$1.89
Share price
-1.72%
Change (1 day)
-53.86%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2025 (TTM): -NZ$40.93 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$47.06 Million a decrease over its 2023 earnings that were of -NZ$25.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$40.93 Million-13.03%
2024 -NZ$47.06 Million83.16%
2023 -NZ$25.69 Million-44.49%
2022 -NZ$46.28 Million3.92%
2021 -NZ$44.54 Million29.81%
2020 -NZ$34.31 Million-31.58%
2019 -NZ$50.15 Million-6.1%
2018 -NZ$53.4 Million38.66%
2017 -NZ$38.52 Million26.63%
2016 -NZ$30.42 Million